Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  Shandong Weigao Group Medical Polymer Company Limited    1066   CNE100000171

SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED

(1066)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Shandong Weigao Medical Polymer : NOTICE OF THE SECOND EXTRAORDINARY GENERAL MEETING

09/21/2020 | 05:16am EST

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

山 東 威 高 集 團 醫 用 高 分 子 製 品 股 份 有 限 公 司

Shandong Weigao Group Medical Polymer Company Limited *

(a joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 1066)

NOTICE OF THE SECOND EXTRAORDINARY

GENERAL MEETING

NOTICE IS HEREBY GIVEN that the second extraordinary general meeting (the "Second Extraordinary General Meeting") of the shareholders of Shandong Weigao Group Medical Polymer Company Limited*(山東威高集團醫用高分子製品股份有限公司)(the "Company") will be held at 2/F, 18 Xingshan Road, Weihai Torch Hi-tech Science Park, Weihai, Shandong, the PRC at 10:00 a.m. on Wednesday, 14 October 2020 for the purpose of considering and, if thought fit, passing the following resolutions of the Company:

ORDINARY RESOLUTION

1. To consider and approve the distribution of an interim dividend of RMB0.062 per share (inclusive of tax) for the six months ended 30 June 2020.

Yours faithfully,

By order of the Board

Shandong Weigao Group Medical Polymer Company Limited*

Zhang Hua Wei

Chairman

Weihai, Shandong, the PRC

22 September 2020

  • For identification purpose only

1

Registered Office:

18 Xingshan Road

Weihai Torch Hi-tech Science Park

Weihai

Shandong Province

the PRC

Principal Place of Business in Hong Kong:

801 Chinachem Century Tower

178 Gloucester Road

Wanchai

Hong Kong

Notes:

  1. A Shareholder who has the right to attend and vote at the Second Extraordinary General Meeting is entitled to appoint one proxy (or more) in writing to attend the Second Extraordinary General Meeting and vote on his behalf in accordance with the Company's Articles of Association. The proxy need not be a shareholder of the Company. Enclosed herewith is a form of proxy for use in the Second Extraordinary General Meeting. Any Shareholder who wishes to appoint a proxy should Second review the form of proxy for use in the Second Extraordinary General Meeting. For any Shareholder who has appointed more than one proxies, such proxies shall only vote on poll. In the case of joint registered holders, the proxy form may be signed by any joint registered holder. In the case that more than one of such joint registered holders are present at any meeting personally or by proxy, then one such joint registered holders so present whose name stands second on the register of members of the Company in respect of such share shall alone be entitled to vote in respect thereof.
  2. All Shareholders shall appoint its proxy in writing. To be valid, a form of proxy together with a power of attorney or other authority, if any, under which it is signed or certified by a notary or an official copy of that power of attorney or authority, must be delivered at the Company's H Shares registrar, Tricor Standard Limited, at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong not less than 24 hours before the time appointed for holding the Second Extraordinary General Meeting or 24 hours before the time designated for voting.
  3. Shareholders and their proxies attending the Second Extraordinary General Meeting shall produce their proof of identification.

2

  1. For the purpose of determining the identity of shareholders who are entitled to attend and vote at the Second Extraordinary General Meeting, the register of members will be closed from Friday, 9 October 2020 to Wednesday, 14 October 2020, both days inclusive, during which period no transfer of shares will be effected. In order to qualify for attending at the Second Extraordinary General Meeting, all transfers accompanied by the relevant share certificates must be lodged with the Company's H Shares registrar at Level 54, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong not later than 4:30 p.m. on Thursday, 8 October 2020.
  2. The Second Extraordinary General Meeting is expected not to exceed half a day, and all shareholders and proxies shall be responsible for their own traveling and accommodation expenses.
  3. Pursuant to Article 80 of the Company's Articles of Association all votes of the Shareholders at the general meetings must be taken by poll.
  4. Any enquiries about this notice and the Second Extraordinary General Meeting shall be sent for the attention to Ms. Yan Yucai at 8/F, 18 Xingshan Road, Weihai Torch Hi-tech Science Park, Weihai, Shandong Province, the PRC (Tel. (86) 631 5660715) or Ms. Phillis Wong at 801, Chinachem Century Tower, 178 Gloucester Road, Wanchai, Hong Kong (Tel: (852) 28381490).

As at the date of this notice, the Board comprises:

Mr. Zhang Hua Wei (Executive Director)

Mr. Long Jing (Executive Director)

Mr. Wang Yi (Executive Director)

Mr. Gong Jian Bo (Executive Director)

Mrs. Zhou Shu Hua (Non-executive Director)

Mr. Lo Wai Hung (Independent non-executive Director)

Mrs. Fu Ming Zhong (Independent non-executive Director)

Mrs. Wang Jin Xia (Independent non-executive Director )

3

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Shandong Weigao Group Medical Polymer Co. Ltd. published this content on 21 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 September 2020 09:14:11 UTC


© Publicnow 2020
All news about SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED
2020SHANDONG WEIGAO MEDICAL POLYMER : Weigo Group's Unit to Acquire Wego Healthcare ..
MT
2020SHANDONG WEIGAO MEDICAL POLYMER : Weigao Group's Shares Jump 3% on Purchase of $..
MT
2020SHANDONG WEIGAO GROUP MEDICAL POLYME : Ex-dividend day for interim dividend
FA
2020SHANDONG WEIGAO MEDICAL POLYMER : Notice of the second extraordinary general mee..
PU
2020SHANDONG WEIGAO MEDICAL POLYMER : Proxy form for the second extraordinary genera..
PU
2020SHANDONG WEIGAO MEDICAL POLYMER : Interim report 2020
PU
2020SHANDONG WEIGAO MEDICAL POLYMER : (1) supplementing the terms and increasing the..
PU
2020SHANDONG WEIGAO MEDICAL POLYMER : Notice of extraordinary general meeting
PU
2020SHANDONG WEIGAO MEDICAL POLYMER : Proxy form for the extraordinary general meeti..
PU
2020SHANDONG WEIGAO MEDICAL POLYMER : Proposed interim dividend and notice of the se..
PU
More news
Financials
Sales 2020 11 353 M 1 756 M 1 756 M
Net income 2020 2 145 M 332 M 332 M
Net cash 2020 257 M 39,7 M 39,7 M
P/E ratio 2020 31,4x
Yield 2020 0,94%
Capitalization 67 202 M 8 669 M 10 392 M
EV / Sales 2020 5,90x
EV / Sales 2021 4,79x
Nbr of Employees 10 153
Free-Float 52,1%
Chart SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED
Duration : Period :
Shandong Weigao Group Medical Polymer Company Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 15,14 CNY
Last Close Price 14,86 CNY
Spread / Highest target 26,4%
Spread / Average Target 1,88%
Spread / Lowest Target -42,9%
EPS Revisions
Managers and Directors
NameTitle
Jing Long Chief Executive Officer & Executive Director
Hua Wei Zhang Chairman & Compliance Officer
Dong Mei Bi Chairman-Supervisory Board
Xue Feng Wu Chief Financial Officer
Yi Wang Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED-12.90%8 903
COLOPLAST A/S2.17%32 940
TELEFLEX INCORPORATED-7.15%17 795
TOP GLOVE CORPORATION BHD.6.54%12 925
HARTALEGA HOLDINGS7.08%11 030
SUPERMAX CORPORATION16.47%4 527